PFE 250103 23.50P (PFE250103P23500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

PFE250103P23500

Watchlist

0.01
0.000.00%

15min DelayClose Jan 3 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Bird Flu Claims First U.S. Life in Louisiana
Seeking Alpha17:22 ET
Pfizer Options Spot-On: On January 6th, 203.66K Contracts Were Traded, With 3.27 Million Open Interest
Moomoo News16:30 ET
Market Climbed Monday Just Past Santa Rally High Water Mark | Wall Street Today
Kevin Travers16:22 ET
FDA Issues First Draft Guidance on Use of AI in Drug, Medical Device Development
Seeking Alpha12:52 ET
CES Tech Conference Week Starts with Nvidia and Chips Climbing | Live Stock
Kevin TraversJan 6 10:52 ET
CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices
BenzingaJan 6 10:40 ET

Comments

Deep Sea

12 hours ago

$Pfizer (PFE.US)$
The stock has broken the 26.83 resistance. Next hit point will be 27.15.

Deep Sea

Yesterday 11:52

$Pfizer (PFE.US)$
Malaysia saw 327 cases of human metapneumovirus (HMPV) infections in 2024, a 45 per cent rise from the 225 cases in 2023.
The Health Ministry said on Jan 4 that HMPV – a respiratory tract infection caused by a virus in the Pneumoviridae family – is not a new disease.
Those with HMPV typically experience symptoms similar to those of a common cold, but in more severe cases the symptoms can progress to bronchitis or pneumonia.
Malaysia recorded 327 HMPV cases in 2024; Health Ministry urges public to remain vigilant | The Straits Times

Stock_Drift

Jan 3 16:39

$Pfizer (PFE.US)$ $Sangamo Therapeutics (SGMO.US)$

Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership

Stock_Drift

Jan 3 16:38

$Pfizer (PFE.US)$

Here’s Why Pfizer Inc. (PFE) Is Among The Stocks Targeted By Activist Hedge Funds

Deep Sea

Jan 3 04:00

$Pfizer (PFE.US)$
Updates with response from Bristol-Myers Squibb in the fourth and fifth paragraphs.
Drugmakers including Pfizer (PFE), Bristol-Myers Squibb (BMY) and Sanofi (SNY) plan to raise US list prices on at least 250 branded medications, including COVID-19 treatments, cancer cell therapies and vaccines, at the start of 2025, Reuters reported Tuesday, citing data from the healthcare research firm 3 Axis Advisors.
Most of the price hikes are below 10% and are to list prices, which do not i...